0.5750
0.0000
(0.00%)
At close: March 7 at 9:59:01 AM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
14,103.1030
14,103.1030
14,577.7680
12,092.7760
12,814.2000
Operating Income
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,814.2000
Other Income Expense
--
--
--
--
66.5030
Pretax Income
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,747.6970
Net Income Common Stockholders
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,747.6970
Diluted NI Available to Com Stockholders
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,747.6970
Basic EPS
-0.87
-0.87
-1.15
-1.12
-1.49
Diluted EPS
-0.87
-0.87
-1.15
-1.12
-1.49
Basic Average Shares
16,163.3660
16,163.3660
12,671.5720
10,816.4120
8,535.8730
Diluted Average Shares
16,163.3660
16,163.3660
12,671.5720
10,816.4120
8,535.8730
Total Expenses
14,103.1030
14,103.1030
14,577.7680
12,092.7760
12,814.2000
Net Income from Continuing & Discontinued Operation
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,747.6970
Normalized Income
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,814.2000
EBIT
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,814.2000
EBITDA
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,814.2000
Net Income from Continuing Operation Net Minority Interest
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,747.6970
Total Unusual Items Excluding Goodwill
--
--
--
--
66.5030
Total Unusual Items
--
--
--
--
66.5030
Normalized EBITDA
-14,103.1030
-14,103.1030
-14,577.7680
-12,092.7760
-12,880.7030
12/31/2021 - 7/2/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CHM.AX Chimeric Therapeutics Limited
0.0050
0.00%
ALA.AX Arovella Therapeutics Limited
0.0820
+1.23%
CYTOF Altamira Therapeutics Ltd.
0.0601
0.00%
FBIOP Fortress Biotech, Inc.
5.19
-1.14%
DYAI Dyadic International, Inc.
1.2380
+3.17%
LSB LakeShore Biopharma Co., Ltd
1.6900
+3.68%
RADX Radiopharm Theranostics Limited
4.4650
+1.71%
IMU.AX Imugene Limited
0.0240
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
7.66
+7.74%
SLRX Salarius Pharmaceuticals, Inc.
0.6262
+5.56%